Publicaciones en las que colabora con Francisco Javier Rodríguez Berrocal (12)

2020

  1. Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial

    Scientific Reports, Vol. 10, Núm. 1

2017

  1. Evaluation of an automated commercial ELISA method for calprotectin determination in pleural fluid

    Clinical Chemistry and Laboratory Medicine

  2. Highly sensitive marker panel for guidance in lung cancer rapid diagnostic units

    Scientific Reports, Vol. 7

  3. Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis

    BMC Cancer, Vol. 17, Núm. 1

2015

  1. Pretreatment levels of the serum biomarkers CEA, CYFRA 21–1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients

    SpringerPlus, Vol. 4, Núm. 1

  2. Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancer

    PLoS ONE, Vol. 10, Núm. 5

2014

  1. Evaluation of pleural effusion sCD26 and DPP-IV as diagnostic biomarkers in lung disease

    Scientific Reports, Vol. 4

2013

  1. Levels of PEDF in pleural effusions from lung adenocarcinoma and benign disease patients

    Disease Markers, Vol. 34, Núm. 6, pp. 425-430

2012

  1. Calprotectin: A novel biomarker for the diagnosis of pleural effusion

    British Journal of Cancer, Vol. 107, Núm. 11, pp. 1876-1882

2010

  1. Validation of PEDF as a potential biomarker for NSLC

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 5, pp. 61-62

2009

  1. In the search of early stages biomarkers for non small cell lung cancer

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 3, pp. 155-155

  2. Proteomic approach to improve the diagnosis of malignant pleural effusions

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 3, pp. 150-150